2009
DOI: 10.1128/aac.00998-08
|View full text |Cite
|
Sign up to set email alerts
|

In Vitro Activities of Fluconazole and Voriconazole against Clinical Isolates of Candida spp. Determined by Disk Diffusion Testing in Turin, Italy

Abstract: The in vitro activities of fluconazole and voriconazole against 1,024 clinical isolates of Candida spp. were determined by the agar disk diffusion test using the Clinical and Laboratory Standards Institute (CLSI) M44-A guidelines. The results of this investigation demonstrated the broad-spectrum in vitro activity of voriconazole, relative to that of fluconazole, against yeasts tested, in particular fluconazole-resistant isolates, such as Candida krusei that showed high susceptibility to voriconazole. The situa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
11
0

Year Published

2010
2010
2020
2020

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 21 publications
(14 citation statements)
references
References 16 publications
3
11
0
Order By: Relevance
“…Moreover, a higher frequency of resistance to voriconazole was seen in C. albicans than in non-albicans Candida, but the difference was not statistically significant. A similar susceptibility pattern was also observed in other studies carried out in India, Turin and Italy [55], and the results of these studies validate the idea that voriconazole could be a promising antifungal agent against active infections caused by Candida spp. innately resistant to fluconazole.…”
Section: Discussionsupporting
confidence: 88%
“…Moreover, a higher frequency of resistance to voriconazole was seen in C. albicans than in non-albicans Candida, but the difference was not statistically significant. A similar susceptibility pattern was also observed in other studies carried out in India, Turin and Italy [55], and the results of these studies validate the idea that voriconazole could be a promising antifungal agent against active infections caused by Candida spp. innately resistant to fluconazole.…”
Section: Discussionsupporting
confidence: 88%
“…The strains were identified by standard methods (cornmeal for blastoconidia, germ-tube formation, pseudohyphae and true hyphae, and growth on CHROMagar™ Candida (BD, Milan, Italy) and with commercially available yeast identification system (API ID32C panels, bioMĂ©rieux, Rome, Italy) [10]. …”
Section: Methodsmentioning
confidence: 99%
“…Biofilms are critical for developing clinical infection. C. albicans and C. parapsilosis, which were often identified in analyzed materials, have lower incidences of fluconazole, voriconazole, amphotericin B, and echinocandins resistance than other NAC species (23)(24)(25)(26). As NAC specie resistance together with prevalence in infections is increasingly being reported (22), NAC species detection and identification must not be neglected.…”
Section: Discussionmentioning
confidence: 99%